Can Periprosthetic Joint Infection of Tumor Prostheses Be Controlled With Debridement, Antibiotics, and Implant Retention?

Grant R McChesney,Humaid Al Farii,Sydney Singleterry,Valerae O Lewis,Bryan S Moon,Robert L Satcher,Justin E Bird,Patrick P Lin,Grant R. McChesney,Valerae O. Lewis,Bryan S. Moon,Robert L. Satcher,Justin E. Bird,Patrick P. Lin
DOI: https://doi.org/10.1097/corr.0000000000003184
IF: 4.755
2024-07-12
Clinical Orthopaedics and Related Research
Abstract:Two-stage revision for periprosthetic joint infection (PJI) in patients who have undergone segmental replacement of the distal femur or proximal tibia after tumor resection can be associated with considerable morbidity, pain, and risk of complications because the procedure often results in removal of long, well-fixed stems from the diaphysis. A less-aggressive surgical approach, such as debridement, antibiotics, and implant retention (DAIR), may be attractive to patients and surgeons because of less morbidity, but the likelihood of eradicating infection in comparison to the traditional two-stage revision is not well established for oncology patients. Furthermore, the relative risk of subsequent amputation for DAIR versus two-stage revision has not been defined for this population.
surgery,orthopedics
What problem does this paper attempt to address?